as on September 13, 2025 at 1:27 am IST
Day's Low
Day's High
0.19%
Downside
2.70%
Upside
52 Week's Low
52 Week's High
11.39%
Downside
177.22%
Upside
Check Bolt Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$9.9M
EPS (TTM)
-16.1733
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-0.4
Industry PE ratio
-3.8535542168674697
P/B Ratio
0PEG Ratio
0EBITDA
-51.8M
Revenue (TTM)
4.2M
Profit Margin
0.00%
Return On Equity TTM
22921900.00%
Track how Bolt Biotherapeutics Inc P/E has moved over time to understand its valuation trends.
Bolt Biotherapeutics Inc in the last 5 years
Lowest (0.00x)
September 15, 2025
Industry (-3.85x)
September 15, 2025
Today (-0.40x)
September 15, 2025
Highest (0.00x)
September 15, 2025
Today’s Price to Earnings Ratio: -0.40x
Compare market cap, revenue, PE, and other key metrics of Bolt Biotherapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $9.9M | NA | -0.4 | 0.00% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Bolt Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bolt Biotherapeutics Inc investment value today
Current value as on today
₹47,703
Returns
Returns from Bolt Biotherapeutics Inc Stock
Dollar Returns*
₹5,139 (+5.14%)
Based on 12 analysts
83.33%
Buy
16.67%
Hold
0.00%
Sell
Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Bolt Biotherapeutics Inc. Average target price of $33.67
Get share price movements and forecasts by analysts on Bolt Biotherapeutics Inc.
What analysts predicted
84.62%UPSIDE
Target Price
$33.67
Current Price
$5.18
Analyzed by
12 Analysts
Target
$33.67
Bolt Biotherapeutics Inc target price $33.67, a slight upside of 84.62% compared to current price of $5.18. According to 12 analysts rating.
Search interest for Bolt Biotherapeutics Inc Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:20% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 1.22M → 1.80M (in $), with an average increase of 32.3% per quarter
Profit Spike
Netprofit is up for the last 3 quarters, -15.93M → -8.56M (in $), with an average increase of 36.7% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 209.2%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 133.1%
Price Dip
In the last 6 months, BOLT stock has moved down by -37.5%
Organisation | Bolt Biotherapeutics Inc |
Headquarters | 900 Chesapeake Drive, Redwood City, CA, United States, 94063 |
Industry | Healthcare |
CEO | Mr. William P. Quinn |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Nathan Ihle Ph.D. | Senior Vice President of Pharmaceutical Operations |
Dr. Michael N. Alonso Ph.D. | Senior Vice President of Research |
Mr. Justin Kenkel | Senior Principal Scientist |
Mr. William P. Quinn | CEO, CFO, President, Secretary & Director |
Mr. Grant Yonehiro C.F.A., M.B.A. | COO & Chief Business Officer |
Ms. Sarah Nemec | Senior VP of Finance & Principal Accounting Officer |
Mr. Wesley Burwell | VP & Head of Human Resources |
Bolt Biotherapeutics Inc share price today is $5.18 as on at the close of the market. Bolt Biotherapeutics Inc share today touched a day high of $5.32 and a low of $5.17.
Bolt Biotherapeutics Inc share touched a 52 week high of $14.36 on and a 52 week low of $4.59 on . Bolt Biotherapeutics Inc stock price today i.e. is closed at $5.18,which is 63.93% down from its 52 week high and 12.85% up from its 52 week low.
Bolt Biotherapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Bolt Biotherapeutics Inc (BOLT) shares with as little as ₹88.27 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.70 in Bolt Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bolt Biotherapeutics Inc share’s latest price of $5.18 as on September 13, 2025 at 1:27 am IST, you will get 1.9305 shares of Bolt Biotherapeutics Inc. Learn more about
fractional shares .